D. Freeman

发表

Predicting frequent COPD exacerbations using primary care data

D. Price, M. Kerkhof, A. Chisholm, 2015, International journal of chronic obstructive pulmonary disease.

Evaluation of inhaler technique and achievement and maintenance of mastery of budesonide/formoterol Spiromax® compared with budesonide/formoterol Turbuhaler® in adult patients with asthma: the Easy Low Instruction Over Time (ELIOT) study

D. Price, S. Bosnic-Anticevich, H. Chrystyn, 2018, BMC Pulmonary Medicine.

Long-acting muscarinic antagonist use in adults with asthma: real-life prescribing and outcomes of add-on therapy with tiotropium bromide

D. Price, Mike Thomas, A. Kaplan, 2015, Journal of asthma and allergy.

ABS74: Large variations in asthma control between UK general practices participating in the asthma control, concordance and tolerance (ACCT) Initiative

D. Price, R. Horne, D. Ryan, 2006 .

Detecting mild COPD is not a waste of resources.

D. Price, J. Cleland, A. Kaplan, 2011, Primary care respiratory journal : journal of the General Practice Airways Group.

Blood eosinophil count and exacerbation risk in patients with COPD

Todor A Popov, D. Postma, I. Pavord, 2017, European Respiratory Journal.

New Approaches for Managing Influenza in Primary Care

D. Fleming, C. Silagy, D. Freeman, 2001 .

Long-acting β2-agonists in COPD

D. Freeman, Daryl Freeman, 2001 .

Using fractional exhaled nitric oxide (FeNO) to diagnose steroid-responsive disease and guide asthma management in routine care

D. Price, D. Ryan, Mike Thomas, 2013, Clinical and Translational Allergy.

Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.

D. Price, K. Ohta, D. Ryan, 2018, The Lancet. Respiratory medicine.

FeNO as predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility; a randomised controlled trial

K. Ohta, D. Ryan, E. Gardener, 2017 .

Blood eosinophilia and the number of exacerbations in COPD patients

D. Postma, I. Pavord, D. Price, 2014 .

British Thoracic Society guidelines for home oxygen use in adults: accredited by NICE

W. MacNee, A. Evans, M. Hardinge, 2015, Thorax.

When should I be considering home oxygen for my patients?

M. Hardinge, D. Freeman, I. Patel, 2016, npj Primary Care Respiratory Medicine.

Use of home oxygen therapy in adults

M. Hardinge, D. Freeman, J. Suntharalingam, 2016 .

The BREATH (Breathlessness Research, Expectations and Treatment Hopes) study: a study in four countries

D. Price, D. Freeman, 2002 .

Symptom-Based Questionnaire for Differentiating COPD and Asthma

D. Price, E. Juniper, R. Nordyke, 2006, Respiration.

Pragmatic randomised controlled trials in COPD and asthma: how to guide clinical practice

N. Snowise, D. Freeman, A. De Soyza, 2022, BMJ Open Respiratory Research.

Primary care and palliative care

D. Price, D. Freeman, 2006, BMJ : British Medical Journal.

Meeting abstracts from the Respiratory Effectiveness Group 2015 Winter Summit – databases and registries around the world: maximizing the yield

Jonathan D. Campbell, D. Postma, C. Rand, 2015, Pragmatic and Observational Research.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Cost effectiveness of leukotriene receptor antagonists versus inhaled corticosteroids for initial asthma controller therapy: a pragmatic trial.

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Symptom-Based Questionnaire for Identifying COPD in Smokers

D. Price, E. Juniper, R. Nordyke, 2006, Respiration.

Earlier diagnosis and earlier treatment of COPD in primary care.

David Price, Jen Cleland, Alan Kaplan, 2010, Primary care respiratory journal : journal of the General Practice Airways Group.

A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study).

D. Price, M. Mugford, E. Juniper, 2011, Health technology assessment.

Efficacy and safety of tiotropium in COPD patients in primary care – the SPiRiva Usual CarE (SPRUCE) study

D. Price, D. Freeman, Angela Lee, 2007, Respiratory research.

Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort.

D. Price, E. Bateman, D. Ryan, 2014, The Lancet. Respiratory medicine.

Progressive breathlessness in COPD - the role of hyperinflation and its pharmacological management.

D. Price, A. Kaplan, D. Freeman, 2005, Primary care respiratory journal : journal of the General Practice Airways Group.

Real-world research and its importance in respiratory medicine

N. Roche, G. Brusselle, A. Chisholm, 2015, Breathe.

Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma

E. Juniper, L. Shepstone, J. Murdoch, 2010, PharmacoEconomics.

Leukotriene antagonists as first-line or add-on asthma-controller therapy.

D. Price, E. Juniper, L. Shepstone, 2011, The New England journal of medicine.

The Importance of Self-Management in the Context of Personalized Care in COPD

D. Freeman, S. Holmes, Sally J Singh, 2022, International journal of chronic obstructive pulmonary disease.

Adjunctive treatment with oral AKL1, a botanical nutraceutical, in chronic obstructive pulmonary disease

D. Price, Andrew M. Wilson, D. Sexton, 2014, International journal of chronic obstructive pulmonary disease.

British Thoracic Society quality standards for home oxygen use in adults

W. MacNee, C. Davey, M. Hardinge, 2017, BMJ Open Respiratory Research.

Questions for COPD diagnostic screening in a primary care setting.

D. Price, R. Nordyke, R. Halbert, 2005, Respiratory medicine.